0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Dermatology |

In This Issue of JAMA Dermatology FREE

JAMA Dermatol. 2013;149(5):521. doi:10.1001/jamadermatol.2013.15.
Text Size: A A A
Published online

FACTORS PREDICTIVE OF RECURRENCE AND DEATH FROM CUTANEOUS SQUAMOUS CELL CARCINOMA

Approximately 250 000 cutaneous squamous cell carcinomas (CSCCs) are diagnosed annually in the United States. Though most CSCCs are easily cured, a subset of them recur, metastasize, and cause death. In this 10-year retrospective cohort study, Schmults et al identified 5 risk factors that contribute to poor outcomes: tumor diameter greater than 2 cm, poor differentiation, depth of invasion beyond the subcutaneous fat, perineural invasion, and location on the ear, temple, or anogenital region. Because these 5 risk factors may be among the most significant drivers of CSCC outcomes, clinical trials regarding nodal staging and adjuvant therapy may be targeted at patients with 1 or more of the risk factors.

See Article

STANDARDIZING TRAINING FOR PSORIASIS MEASURES

Several instruments have been developed to measure disease severity in psoriasis. Among them, the Psoriasis Area and Severity Index (PASI) is most frequently used, not only for quantifying extent of disease but also as a validated measure of response to treatment. Without training, evaluators assign PASI scores with substantial variability. In this equivalency study, Armstrong et al demonstrate that an online PASI training video can be an effective tool in improving accuracy of PASI scoring.

See Article

PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTI–LAMININ 332 AUTOANTIBODIES DETECTED BY A NOVEL ENZYME-LINKED IMMUNOSORBENT ASSAY IN MUCOUS MEMBRANE PEMPHIGOID

Mucous membrane pemphigoid (MMP) is a heterogeneous group of autoimmune diseases encompassing chronic, inflammatory, subepithelial blistering diseases that predominantly affect mucous membranes and lead to scarring. The 2 major autoantigens of MMP are BP180 and laminin 332 (Lam332), which are both components of anchoring filaments. The MMP subtype that demonstrates anti-Lam332 antibodies has been reportedly associated with an increased relative risk of cancer. In this multicenter retrospective study, Bernard et al demonstrated the usefulness of a novel enzyme-linked immunosorbent assay to identify anti-Lam322 serum samples from patients with MMP. Anti-Lam322 antibodies were mainly detected in patients with severe MMP, but not preferentially among those with malignant neoplasms.

See Article

PREVALENCE OF PILOMATRICOMA IN TURNER SYNDROME

Pilomatricomas are benign cutaneous adnexal tumors that arise from the outer root sheath cells in the hair follicle. The prevalence of solitary pilomatricoma among the general population is unknown. In this retrospective medical record review, Handler et al demonstrate a prevalence rate of 2.6% for pilomatricoma among a cohort of 311 patients with Turner syndrome. Physicians caring for patients with Turner syndrome should be aware of the prevalence of pilomatricoma among these patients, and pilomatricoma should be suspected in patients with solitary, hard, mobile, nontender, bluish nodules on the head or neck.

See Article

EFFECT OF STORE AND FORWARD TELEDERMATOLOGY ON QUALITY OF LIFE

For many dermatologic conditions, the health outcome measure of principal importance is self-reported quality of life. Although research on quality of life and dermatologic conditions is well represented in the literature, information on teledermatology's effect on quality of life is virtually absent. In this randomized clinical trial, Whited et al demonstrate that at 3 or 9 months after referral, store and forward teledermatology did not result in a statistically significant difference in skin-related quality of life compared with in-person consultations. These results have important operational implications for teledermatology.

See Article

First Page Preview

View Large
First page PDF preview

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

478 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs